Juvenile nasopharyngeal angiofibroma
- Authors: Krasnov A.S.1, Grachev N.S.1, Vorozhtsov I.N.1, Tereschenko G.V.1
-
Affiliations:
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation
- Issue: Vol 19, No 4 (2020)
- Pages: 185-197
- Section: LITERATURE REVIEW
- Submitted: 22.12.2020
- Accepted: 22.12.2020
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/435
- DOI: https://doi.org/10.24287/1726-1708-2020-19-4-185-197
- ID: 435
Cite item
Full Text
Abstract
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that affects almost exclusively male adolescents. Usually, symptoms of JNA are detected within 15–24 months before seeking medical help. JNA is mainly diagnosed in patients aged 14 to 25 years. Angiofibroma consists of a complex mixture of blood vessels and a fibrous stroma. This feature of their structure determines the property of the tumor to bleed massively even after minimal surgical procedures. The tumor usually grows posteriorly and upward, involving the sphenoid sinus. Under certain circumstances, it can spread anteriorly into the nasal cavity with the involvement of ethmoid cells. With lateral spread, it affects the space of the pterygo-palatine fossa and can also spread into the infratemporal fossa through the expanded pterygo-maxillary fissure, into the region of the chewing muscles and soft tissues of the cheek. In this review, we briefly outline the study history, and current aspects of etiology, pathogenesis, diagnostic and treatment methods of JNA.
Keywords
About the authors
A. S. Krasnov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation
Author for correspondence.
Email: alexey.s.krasnov@gmail.com
ORCID iD: 0000-0003-1099-9332
Alexey S. Krasnov, а researcher at the Department of Diagnostic Radiology
1 Samory Mashela St., Moscow 117997
Russian FederationN. S. Grachev
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation
ORCID iD: 0000-0002-4451-3233
Moscow Russian Federation
I. N. Vorozhtsov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation
ORCID iD: 0000-0003-3986-3770
Moscow Russian Federation
G. V. Tereschenko
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation
ORCID iD: 0000-0001-7317-7104
Moscow Russian Federation
References
Supplementary files
